Cano Health Faces Financial Challenges
Cano Health is experiencing setbacks and plans to sell the company due to financial challenges. They are also reducing the workforce and exploring strategic options.
Cano Health, a primary-care provider, is experiencing significant setbacks as it issues a warning about its ability to sustain itself as a "going concern" and announces its intention to sell the company. Following the release of its second-quarter earnings report, Citi analysts have downgraded Cano's stock (ticker: CANO) from Buy to Neutral. They have also decreased their target price from $4 to 80 cents. Despite acknowledging the company's innovative approach to managing underserved populations, the analysts express concerns about recent financial trends, solvency issues, and other obstacles. As a result, they find it challenging to maintain a more positive outlook on the company's future.
Cano's second-quarter earnings report, released on Thursday, revealed that the company has withdrawn its fiscal year 2023 guidance and initiated the process of selling itself. As of August 9, Cano had approximately $101 million in liquidity, consisting of cash and cash equivalents. However, the company does not believe this amount is sufficient to cover its operating, investing, and financing needs over the next 12 months.
In light of these circumstances, Cano's management has concluded that there is substantial doubt regarding the company's ability to continue as a going concern within the next year, as stated in the release.
In recent news, Cano Health has announced plans to exit operations in multiple states and expects to reduce its workforce by approximately 700 employees in the third quarter. The company has also reported a significant net loss of $270.7 million for the second quarter, compared to a loss of $14.6 million in the previous year. This wider loss is primarily attributed to increased operating expenses.
These announcements have had a negative impact on the company's stock, with shares plummeting by 49% to 78 cents during premarket trading on Friday.
Cano Health's interim chief executive, Mark Kent, stated that the company is evaluating strategic interest from potential partners in order to ensure the continued care for their patients while maximizing value for stakeholders. Despite these challenges, the company's mission and vision remain unchanged. However, in order to achieve profitability, a new approach with a strong operational foundation is necessary.
Notably, there were previous reports suggesting that Humana (HUM) or CVS Health (CVS) had expressed interest in acquiring Cano Health. However, it was later reported that CVS had withdrawn from the potential acquisition.